BioSpace News Archive

Ampio Pharmaceuticals, Inc. announced that it has received notification from The NYSE American LLC stating that the Company has regained compliance with the NYSE American’s continued listing standards.

Everest Medicines, a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced that the first phase of its global manufacturing site dedicated to mRNA vaccine production in Jiashan, Zhejiang Province has initiated operation and successfully carried out trial production runs.